-
Mashup Score: 30ADAPTABLE: Similar Benefit, Bleeding Risk With Low- and High-Dose Aspirin For Secondary Prevention - American College of Cardiology - 3 year(s) ago
In a trial designed to try to answer the longstanding question of the optimal dose of aspirin for secondary prevention in patients with established atherosclerotic cardiovascular disease, no significant difference was found in cardiovascular events or major bleeding between the 81 mg and 325 mg daily doses, according to results of the ADAPTABLE study presented May 15 during ACC.21 and…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial | Circulation: Cardiovascular Quality and Outcomes - 4 year(s) ago
Background Many large-scale cardiovascular clinical trials are plagued with escalating costs and low enrollment. Implementing a computable phenotype, which is a set of executable algorithms, to ide…
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet-
.#ADAPTABLE trial investigators publish overview of the development & implementation of a computable #phenotype as an efficient method to recruit patients in large-scale multi-isite pragmatic #ClinicalTrials. @PCORI #aspirin #ImpSci #ASCVD #CVD #EHR #costs https://t.co/zQSrm7qvhs https://t.co/0jkMK2M7Ju
-
-
Mashup Score: 0ADAPTABLE: the Future of Big Clinical Trial Design? - 4 year(s) ago
Open-label study relies on EHRs and claims data for outcomes
Source: www.medpagetoday.comCategories: CardiologistsTweet
In a trial designed to try to answer Q of optimal dose of #aspirin for secondary prev. in patients with established atherosclerotic #CVD, no significant diff. found in CV events/major bleeding btwn the 81 mg & 325 mg daily doses. https://t.co/ejnAAh5eLs #ADAPTABLE #ACC21 @NEJM https://t.co/Of8gdrwJPt